The DOI matches its Crossref record; 138 of the 139 references it cites were found in a registry or an index.
Complex chronic comorbidities of COPD
Open accessAbstract
Chronic obstructive pulmonary disease (COPD) is defined by fixed airflow limitation associated with an abnormal pulmonary and systemic inflammatory response of the lungs to cigarette smoke. The systemic inflammation induced by smoking may also cause chronic heart failure, metabolic syndrome and other chronic diseases, which may contribute to the clinical manifestations and natural history of COPD. Thus COPD can no longer be considered a disease only of the lungs, as it is often associated with a wide variety of systemic consequences. A better understanding of the origin and consequences of systemic inflammation, and of potential therapies, will most likely lead to better care of patients with COPD. Medical textbooks and clinical guidelines still largely ignore the fact that COPD seldom occurs in isolation. As the diagnosis and assessment of severity of COPD may be greatly affected by the presence of comorbid conditions, the current authors believe that lung function measurement, noninvasive assessment of cardiovascular and metabolic functions, and circulating inflammatory markers (e.g. C-reactive protein) might help to better characterise these patients. Similarly, preventive and therapeutic interventions should address the patient in their complexity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
2013 ESH/ESC Guidelines for the management of arterial hypertension
Authors Task Force Members, Mancia, G., Fagard, R., Narkiewicz, K., Redon, J., Zanchetti, A., Böhm, M., Christiaens, T., Cífková, R., Backer, G. D., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht151 · Cited by 13,739
Harrison's Principles of Internal Medicine.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-499_2 · Cited by 12,528
Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.169404 · Cited by 11,961
Inflammation, Atherosclerosis, and Coronary Artery Disease
Hansson, G. K. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043430 · Cited by 8,773
Ridker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850
Lopez, A. D., Mathers, C. D., Ezzati, M., Jamison, D. T., & Murray, C. J. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68770-9 · Cited by 5,630
Rabe, K. F., Hurd, S., Anzueto, A., Barnes, P. J., Buist, S. A., Calverley, P., Fukuchi, Y., Jenkins, C., Rodriguez-Roisin, R., van Weel, C., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200703-456so · Cited by 4,925
Self-citationCelli, B. R., MacNee, W., Agustí, A. G. N., Anzueto, A. R., Berg, B., Buist, A. S., Calverley, P. M., Chavannes, N. H., Dillard, T. A., Fahy, B. F., et al. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00014304 · Cited by 4,405
Celli, B. R., Cote, C. G., Marin, J. M., Casanova, C., Montes de Oca, M., Mendez, R. A., Pinto Plata, V., & Cabral, H. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa021322 · Cited by 4,015
Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
CALVERLEY, P. M. A., Anderson, J. A., Celli, B. R., Ferguson, G. T., Jenkins, C. R., Jones, P., Yates, J., & Vestbo, J. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063070 · Cited by 3,234
Research works printed but not linked: 8
- Fabbri LM, Rabe KF. Complexity of patients with multiple chronic diseases. Proceedings of an ERS Research Seminar (Rome, February 11–12, 2007). www.ersnet.org/ers/lr/browse/default.aspx?id_dossier = 67422 Date last accessed: October 31, 2007.
- 2005, Exp Lung Res, 31, 72
- 2007, Curr Opin Pulm Med, 13, 114
- 1996, Diabetes Metab, 22, 37
- 2000, Am J Respir Crit Care Med, 161, A583
- 2006, Cardiovasc Res, 3, e333
- 2005, Cochrane Database Syst Rev, 3, CD005374
- 2007, Curr Opin Pulm Med, 13, 90
Cited by
Sorted by citations
Items 501–600 of 655
NIV: indication in case of acute respiratory failure in obstructive pulmonary diseases
Ambrosino, N., & Corrado, A. (2008) · European Respiratory Society eBooks · doi:10.1183/1025448x.00041002 · Cited by 1
“Although the relationship between AECOPD frequency and severity of airflow obstruction is not particularly close, prevalence of AECOPD increases with disease severity [7], and new evidence indicates a possible role for extrapulmonary factors in their genesis [8].”
BackgroundBals, R., Gillissen, A., Lorenz, J., Morr, H., Pfeifer, M., Randerath, W. J., Rohde, G. G. U., Schultze‐Werninghaus, G., Steinkamp, G., Taube, C., et al. (2010) · Pneumologie · doi:10.1055/s-0029-1244200 · Cited by 1
NIV and pulmonary rehabilitation
Ambrosino, N., Carpenè, N., & Gherardi, M. (2008) · European Respiratory Society eBooks · doi:10.1183/1025448x.00041018 · Cited by 1
Horita, N., & Kaneko, T. (2016) · Respiratory disease series · doi:10.1007/978-981-10-0839-9_8 · Cited by 1
A New GOLD Standard – Pharmacological Interventions of COPD
Tee, A. K. H. (2013) · The Singapore Family Physician · Cited by 1
Cardiovascular Comorbidities in COPD Patients
ES, R. L. R. (2015) · Translational Medicine · doi:10.4172/2161-1025.1000151 · Cited by 1
The Relationship between Peripheral Arterial Disease and Chronic Obstructive Pulmonary Disease
Kakihana, T., & Kohzuki, M. (2017) · Pulmonary Research and Respiratory Medicine - Open Journal · doi:10.17140/prrmoj-se-2-110 · Cited by 1
Usefulness of Biological Clustering Patterns in Chronic Obstructive Pulmonary Disease
Halner, A., & Bafadhel, M. (2019) · Barcelona Respiratory Network · doi:10.23866/brnrev:2018-0016 · Cited by 1
Singh, P. K., Bhatnagar, M., Deore, S. N., Joshi, M., Ahmed, T., Bhowmick, S., & Verma, S. (2020) · International Journal of Science and Research (IJSR) · doi:10.21275/sr201101122343 · Cited by 1
Chronic obstructive pulmonary disease and arterial hypertension: methaphysics and dialectic
Валерьевна, Л. В., Семенович, З. В., Adasheva, T. V., Pavlov, S. V., & Shakhrai, N. B. (2013) · Cardiosomatics · doi:10.26442/cs44977 · Cited by 1
The Natural History of COPD: Beyond Fletcher and Peto
Rennard, S. I., Agusti, A. A., & Vestbo, J. (2015) · Barcelona Respiratory Network · doi:10.23866/brnrev:2015-0011 · Cited by 1
Huang, S., Hsu, C., Yang, Y., Tsai, Y.-H., Tsai, M., Chang, G., Liu, C., Lee, Y.-C., Huang, E. I., & Tsai, Y.-T. (2022) · PLoS ONE · doi:10.1371/journal.pone.0273437 · Cited by 1
STUDY OF LIPID PROFILE AND ATHEROGENIC INDEX IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
FATIMA, D., TIWARI, S., Gowardipe, P. S., & SK, S. (2022) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2022.v15i12.46238 · Cited by 1
Kumari, R., Pandey, M. K., Verma, S. K., & Ahamad, V. (2024) · Indian Journal of Respiratory Care · doi:10.5005/jp-journals-11010-1096 · Cited by 1
“26 The observed elevation of serum IL-6 aligns with its multifunctional role in various inflammatory pathways.”
Study of Serum Surfactant Protein D Levels in Chronic Obstructive Pulmonary Disease Patients
TIWARI, S., FATIMA, D., & Gowardipe, P. S. (2023) · Medical Journal of Dr D Y Patil Vidyapeeth · doi:10.4103/mjdrdypu.mjdrdypu_704_22 · Cited by 1
Chakrabarti, B., McKnight, E., Pearson, M. G., Dowie, L. N., Richards, J., Choudhury-Iqbal, M., Malone, R., Osborne, M., Cooper, C. B., Davies, L., et al. (2025) · npj Primary Care Respiratory Medicine · doi:10.1038/s41533-025-00421-1 · Cited by 1
Czynniki ryzyka przewlekłej obturacyjnej choroby płuc u pacjentów leczonych szpitalnie
Iwanicka-Michałowicz, M., & Grzelewska-Rzymowska, I. (2009) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 1
Całościowa ocena przewlekłej obturacyjnej choroby płuc według raportu GOLD 2011
Grzelewska-Rzymowska, I., & Górski, P. (2013) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 1
Position paper FADOI sulla prevenzione cardiovascolare nei pazienti complessi a rischio
Campanini, G. E. M., Nardi, R., & Pinna, G. (2015) · Italian Journal of Medicine · doi:10.4081/itjm.q.2015.4 · Cited by 1
Clinical Usefulness of Hochuekkito in Patients with COPD
Tatsumi, K. (2011) · 日本東洋醫學雜誌 · doi:10.3937/kampomed.62.329 · Cited by 1
Evaluation of Carotid Intima –Media Thickness in Patients with Chronic Obstructive Pulmonary Disease
Dr Rajani., M. (2016) · Journal of Medical Science And clinical Research · doi:10.18535/jmscr/v4i3.02 · Cited by 1
Platitsyna, N. G., & Викторовна, Б. Т. (2016) · The Clinician · doi:10.17650/1818-8338-2016-10-1-36-42 · Cited by 1
Ignatova, G. L., Blinova, E. V., Belsner, M. S., & Викторовна, Г. И. (2016) · PULMONOLOGIYA · doi:10.18093/0869-0189-2016-26-3-323-327 · Cited by 1
Валерьевна, Г. Т., Демко, И. В., Николаевна, Б. Е., Gordeeva, N. V., Kraposhina, А. Y., & Soloveva, I. A. (2015) · PULMONOLOGIYA · doi:10.18093/0869-0189-2015-25-3-320-326 · Cited by 1
Suhendro, A. S., Santoso, P., & Riswari, S. F. (2017) · Althea Medical Journal · doi:10.15850/amj.v4n1.1016 · Cited by 1
雄志, 長., 格夫, 佐., Schols, A. M. W. J., STEINER, M. C., & Pison, C. M. (2013) · 静脈経腸栄養 · doi:10.11244/jjspen.28.795 · Cited by 1
Horne, B. D., Ali, R. Z., Midwinter, D., Scott-Wilson, C. A., Crim, C. C., Miller, B. E., & Rubin, D. B. (2021) · International Journal of COPD · doi:10.2147/copd.s279645 · Cited by 1
“161 Prior heart failure diagnosis 7 (2) 1 (<1) 2 (1) 4 (3) 0.”
Fernández-Bussy, S., Kornafeld, A., Gonzalo Labarca, T., Abia‐Trujillo, D., Patel, N. M., Johnson, M. M., Reisenauer, J. S., & Herth, F. J. F. (2021) · The Clinical Respiratory Journal · doi:10.1111/crj.13426 · Cited by 1
Guazzi, M., & Fuso, L. (2009) · European Respiratory Society eBooks · doi:10.1183/1025448x.00043015 · Cited by 1
“Thus, both systemic and pulmonary inflammation might be implicated in the complex interplay between respiratory and metabolic dysfunction [145].”
BackgroundLotz, G., & Kersten, N. (2012) · Zentralblatt für Arbeitsmedizin Arbeitsschutz und Ergonomie · doi:10.1007/bf03346170 · Cited by 1
Association between risk factors of metabolic syndrome with lung function
Ahmed, M. S., Amberina, A. R., Rehman, A., & Mirza, U. (2022) · International Journal of Health Sciences · doi:10.53730/ijhs.v6ns4.5691 · Cited by 1
“[24] Central obesity may affect the mechanical performance of the ventilator because it limits the expansion of the diaphragm.”
BackgroundChronic Respiratory Abnormalities in the Multi-Morbid Frail Elderly
Beghé, B., Clini, E. M., & Fabbri, L. M. (2017) · Barcelona Respiratory Network · doi:10.23866/brnrev:2017-0056 · Cited by 7
Cardinal, H., Madore, F., Brophy, J. M., Joseph, L., Hébert, M., Min, S., Boyer, L., & Bogaty, P. M. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.03.139 · Cited by 1
Si, O., Nersesyan, Z., & Морозова, Т. Е. (2020) · PULMONOLOGIYA · doi:10.18093/0869-0189-2020-30-3-278-284 · Cited by 1
Pharmacotherapy of Chronic Obstructive Pulmonary Disease: Focus on Arformoterol Tartrate
King, P. T. (2009) · Clinical Medicine Therapeutics · doi:10.4137/cmt.s2584 · Cited by 1
Meldrum, C. A. (2014) · Deep Blue (University of Michigan)
Rano prepoznavanje i dijagnoza kronične opstruktivne plućne bolesti
Dugac, A. V., & Samaržija, M. (2014) · Medix : specijalizirani medicinski dvomjesečnik
Broncopneumopatia cronica ostruttiva e comorbidità croniche
Nozzoli, G. E. C., Gensini, G., & Fabbri, L. M. (2013) · Italian Journal of Medicine · doi:10.4081/itjm.2011.1.s1
Επιπολασμός της χρόνιας αποφρακτικής πνευμονοπάθειας στην Κύπρο
Ζαχαριάδης, Α. (2013) · doi:10.12681/eadd/29243
Di, G., Di, D., La, S., Ditta, V., & Stefania, M. (2012) · InTech eBooks · doi:10.5772/28304
“[19,20]”
Chronic obstructive pulmonary disease – multisistemic disease
Matanić, D., Flego, V., Barković, I., Zeba, I., Kupanovac, Ž., & Bulat-Kardum, L. (2009) · Bioline International (Bioline International)
Chronic Obstructive Pulmonary Disease in Primary Care - From Diagnosis to Therapy
Rovatti, E., Capelli, O., Isabella, M., Cacciapuoti, I., & Brambill, A. (2012) · InTech eBooks · doi:10.5772/36836
“Some of these more often coexist and may be correlated, both for shared risk factors that impact on the mutual development (Fabbri et al, 2008), although the risk of comorbidity may also be the result of consequences of COPD, for example, reduced physical activity.”
Stupnitskaya, A. Y. (2014) · PULMONOLOGIYA · doi:10.18093/0869-0189-2014-0-1-43-47
Mineo, D., & Mineo, T. C. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201209-1751ed
Lessons from Multidisciplinary Cross-Fertilization
Rennard, S. I. (2012) · Proceedings of the American Thoracic Society
Systemic inflammation in chronic pulmonary diseases – are we here now?
Šuškovič, S. (2010) · Slovenian Medical Journal
Management of Inflammation in Chronic Obstructive Pulmonary Disease-Update
Barman, R. C., Alam, M. T., Islam, M. S. U., Ahmed, S. A. M., Biswas, G., Howlader, M. A. A. R., & Fattah, S. A. (2013) · Faridpur Medical College Journal · doi:10.3329/fmcj.v8i1.16897
La qualité de vie dans tous ses états
Lipovetsky, G., Roche, N., Ninot, G., Bourbeau, J., & Chavignay, É. (2010) · Revue des Maladies Respiratoires Actualités · doi:10.1016/s1877-1203(10)70146-4
Complessità del paziente con insufficienza respiratoria cronica associata a BPCO
Sgambato, F., & Clini, E. M. (2011) · Italian Journal of Medicine · doi:10.1016/j.itjm.2011.01.022
“[27] Fabbri LM, Luppi F, Beghé B, Rabe KF.”
BackgroundPulmonary comorbidities associated with chronic obstructive pulmonary disease
Luppi, F., Beghé, B., & Roversi, P. (2012) · Italian Journal of Medicine · doi:10.4081/itjm.2012.265
Introduzione: broncopneumopatia cronica ostruttiva e comorbilità croniche
Nozzoli, C., Genuini, G., & Fabbri, L. M. (2011) · Italian Journal of Medicine · doi:10.1016/j.itjm.2011.01.002
BPCO e altre malattie polmonari croniche
Luppi, F., Beghé, B., & Roversi, P. (2011) · Italian Journal of Medicine · doi:10.1016/j.itjm.2011.06.002
“[3] Fabbri LM, Luppi F, Beghé B, Rabe KF.”
BackgroundCost of Non-Respiratory Drugs in Copd
Sina, A., & Shabani, Z. (2013) · Academic Journal of Interdisciplinary Studies · doi:10.5901/ajis.2013.v2n8p82
The extra-pulmonary effects of chronic obstructive pulmonary disease (COPD)
John, M. (2014) · Nottingham ePrints (University of Nottingham)
Statistically significant or clinically useful? From population studies to patient care
Brusasco, V. (2009) · European Respiratory Journal · doi:10.1183/09031936.00061509
“In this scenario, systemic inflammation would be a cause rather than a consequence of COPD and the C-reactive protein (CRP) has been proposed as one of the major culprits [ 4 ].”
BackgroundGenetic susceptibility to asbestos and tobacco smoke related non-malignant pleuropulmonary changes
Kukkonen, M. K. (2013) · Työväentutkimus Vuosikirja
Rennard, S. I., & Vestbo, J. (2011) · Postgraduate Medical Journal · doi:10.1136/pgmj.2010.151498rep
Tomographic ventilation-perfusion lung scintigraphy in cardiopulmonary disease
Jögi, J. (2011) · Lund University Publications (Lund University)
Zheng, L. (2014) · University Library - University of Saskatchewan (University of Saskatchewan)
Postępowanie w ciężkiej postaci przewlekłej obturacyjnej choroby płuc
Ambrosino, N., Gherardi, M., & Carpenè, N. (2009) · Via Medica Journals
Rabe, K. F., Wedzicha, J. A., & Albrechts, C. (2011)
NTproBNP and Cystatin C in patients with acute exacerbation of chronic pulmonary disease
Pérez‐Calvo, J. I., Marteles, M. S., Ruiz-Ruiz, F.-J., Morales‐Rull, J. L., & Nieto-Rodríguez, J. A. (2010)
Modulation of Human Rhinovirus-Induced Epithelial Responses by Cigarette Smoke
Hudy, M. H. (2013) · Libraries and Cultural Resources (University of Calgary) · doi:10.11575/prism/26978
Molecular Pathogenesis of Fibulin-4 Associated Aortic Aneurysms
Ramnath, N. W. M. (2014) · RePub (Erasmus University Rotterdam)
Time and Economic Burden of Comorbidities Among COPD Inpatients
Liu, J., Ma, J., Wang, J., Zeng, D., Song, H., Wang, L., & Cao, Z. (2016) · Lecture notes in computer science · doi:10.1007/978-3-319-29175-8_17
“COPD can no longer be considered a disease only of the lungs, as it is often associated with a wide variety of systemic consequences [5].”
BackgroundEarly chronic obstructive pulmonary disease : Beyond spirometry
Brebner, J. (2013) · World Journal of Respirology · doi:10.5320/wjr.v3.i3.57
Systemic Therapeutic Strategies for COPD.
Tatsumi, K. (2010) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.99.1342
Flego, V., Zeba, I., & Bulat-Kardum, L. (2009)
Zheleznyakova, N. M. (2012) · CyberLeninK (CyberLeninka)
[Comorbidities in patients with chronic obstructive pulmonary disease].
Burgel, P. (2011) · PubMed
Reducing the burden of chronic obstructive pulmonary disease (part II)
Oryginalna, P., & Batura‐Gabryel, H. (2009)
Demochko, E. A., Анатольевна, Д. Е., Minushkina, L. O., & Олеговна, М. Л. (2014)
ASSESSMENT OF INFLUENCE THE POLLUTION ATMOSPHERIC AIR IN ULAN-BATOR CITY ON THE POPULATION INCIDENCE
Александровна, Е. Т., Nv, E., Budnyam, S., Maltuguyeva, N. S., & Stolbov, A. B. (2014)
COPD: recognizing the susceptible smoker
Hoonhorst, S. J. M. (2014) · University of Groningen research database (University of Groningen / Centre for Information Technology)
Nutrition Support for Pulmonary Failure
Matos, A. A., Manzanares, W., & Nava, V. M. S. (2015) · CRC Press eBooks · doi:10.1201/b18386-34
Hospitalization for COPD Exacerbation: An Opportunity for Azithromycin?
Taylor, B., Patel, N., Cheng, S., Brown, A., & Taylor, S. P. (2016) · Insights in Chest Diseases · doi:10.21767/2577-0578.10013
Luppi, F., Beghé, B., Corbetta, L., & Fabbri, L. M. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-374001-4.00041-9
Editorial Comorbidities in Chronic Obstructive Pulmonary Disease from Assessment to Treatment
Clini, E. M., Boschetto, P., Lainščak, M., & Janssens, W. (2014)
Matsuoka, H. (2016) · International Journal of Respiratory and Pulmonary Medicine · doi:10.23937/2378-3516/1410038
“COPD, Coronary artery disease, Clinical features, Prevalence Recently, COPD has been recognized as a systemic inflammatory disease [3,4], and it is associated with an increased risk of cardiovascular disease (CVD).”
BackgroundKomorbiditeti u kroničnoj plućnoj opstruktivnoj bolesti
Ogresta, D. (2014)
Zaburzenia funkcji tarczycy w przewlekłej obturacyjnej chorobie płuc
Miłkowska-Dymanowska, J., Białas, A. J., Laskowska, P., Górski, P., & Piotrowski, W. J. (2017) · Advances in respiratory medicine · doi:10.5603/arm.50850
Utility of the new gold classification for COPD in alpha one antitrypsin deficiency
Pillai, A. (2017) · University of Birmingham Institutional Research Archive (University of Birmingham)
Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnoea
McNicholas, W. T. (2017) · European Respiratory & Pulmonary Diseases · doi:10.17925/erpd.2017.03.01.23
Kang, B. M., Park, H., Lee, Y. M., & Song, K. (2017) · Journal of Nutrition and Health · doi:10.4163/jnh.2017.50.6.585
“Considering that hypertension is the most common disease that COPD patients in Korea suffer from (51% of all COPD patients) and that it affects prognosis, blood pressure management seems to be necessary.(1,26) Total cholesterol was greater in the NCOPD group than the COPD group, but the levels of both groups were incl…”
BackgroundВІКОВІ ТА ГЕНДЕРНІ АСПЕКТИ ХРОНІЧНОГО ОБСТРУКТИВНОГО ЗАХВОРЮВАННЯ ЛЕГЕНЬ
Maksiv, H. Y., Мірошнік, Г. О., Mialiuk, O. P., Марущак, М. І., & Liublinska, M. S. (2018) · Медсестринство · doi:10.11603/2411-1597.2017.3.8522
Monografia Giovani FADOI: dalle evidenze alla pratica clinica
Gnerre, G. E. P., Gerloni, R., Cenci, C., Pasquini, M. C., & Poggiano, M. R. (2018) · Italian Journal of Medicine · doi:10.4081/itjm.q.2018.1
Seo, M. S., Hwang, I. C., Shim, J., Ahn, H. Y., & Kim, S. (2018) · Psychology Health & Medicine · doi:10.1080/13548506.2018.1467020
Understanding and Diagnosing Asthma and COPD by Metabolomics
Ho, W. E., & Wong, W. S. F. (2018) · Translational bioinformatics · doi:10.1007/978-981-10-8764-6_8
Osteoporosis in Chronic obstructive Pulmonary Disease (COPD) Patients
Islam, M. K., Hossain, F. S., Chowdhury, M. K., & Biswas, P. K. (2018) · Journal of Medicine · doi:10.3329/jom.v19i2.37231
Walsh, J., Scott, A., & Rutherford, R. M. (2018) · Current Geriatrics Reports · doi:10.1007/s13670-018-0253-1
Chronic Obstructive Pulmonary Disease and Extrapulmonary Effects: Cognitive Impairment
Piya-amornphan, N., Santiworakul, A., & Nawarat, J. (2018) · Journal of Health Science and Medical Research · doi:10.31584/jhsmr.201829 · Cited by 1
Suehiro, C. L. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2018.tde-27092018-122854
Metadata
- Authors
- Fabbri, L. M., Luppi, F., Beghé, B., & Rabe, K. F.
- Affiliations
- University of Modena and Reggio Emilia (IT)
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2007-12-31
- Volume
- 31
- Issue
- 1
- Pages
- 204-212
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- OpenAlex
- W2165340553
- Cited by
- 660
- References
- 139
- Citations by year
- 2026: 8 · 2025: 16 · 2024: 20 · 2023: 17 · 2022: 26 · 2021: 19 · 2020: 35 · 2019: 25 · 2018: 36 · 2017: 48 · 2016: 31 · 2015: 50 · 2014: 68 · 2013: 55 · 2012: 59
- FWCI
- 28.24
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- cc-by
- Locations
- European Respiratory Journal (publishedVersion)
- PubMed (publishedVersion)
- BOA (University of Milano-Bicocca) (submittedVersion)
- IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion, cc-by)
- INFM-OAR (INFN Catania) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Keywords
- chronic obstructive pulmonary disease, comorbidities, systemic inflammation, chronic heart failure, metabolic syndrome, cigarette smoking, C-reactive protein, inflammatory markers, COPD severity assessment, cardiovascular function, COPD management
- MeSH terms
- Chronic Disease, Health Status, Humans, Inflammation, Lung, Models, Biological, Prognosis, Risk Factors, Smoking, Pulmonary Medicine, Comorbidity, Guidelines as Topic, Pulmonary Disease, Chronic Obstructive, Overweight
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review